Skip to main content
. 2007 Sep 25;9(5):R62. doi: 10.1186/bcr1768

Table 2.

Two-year average annual breast cancer incidence and mortality rates in non-Hispanic white women

San Francisco Bay area The rest of California

2000–2001
Rate (95% CI)
2003–2004
Rate (95% CI)
2000–2001
Rate (95% CI)
2003–2004
Rate (95% CI)
Mortality rate 27.4 (25.7–29.2) 26.5 (24.9–28.3) 27.8 (27.1–28.6) 25.4 (24.6–26.1)
In situ incidence rate 35.6 (33.6–37.7) 33.2 (31.3–35.2) 30.5 (29.7–31.4) 29.5 (28.7–30.4)
Invasive incidence rate 160.0 (155.9–164.3) 140.8 (136.9–144.8) 151.7 (149.9–153.6) 135.1 (133.4–136.9)
 Histologic subtypea
  Ductal 110.9 (107.5–114.5) 97.0 (93.7–100.3) 98.9 (97.4–100.4) 88.4 (87.0–89.8)
  With lobular component 29.6 (27.8–31.5) 26.9 (25.2–28.7) 30.4 (29.6–31.2) 27.0 (26.2–27.8)
 Age at diagnosis (years)a
  <40 13.1 (11.5–15.0) 14.0 (12.1–16.1) 13.0 (12.2–13.9) 13.0 (12.2–13.9)
  40–69 305.5 (295.4–315.8) 263.1 (253.9–272.5) 287.3 (282.8–291.9) 255.5 (251.3–259.7)
  ≥70 535.3 (511.7–559.8) 475.7 (452.4–499.9) 511.6 (501.3–522.0) 447.8 (438.0–457.7)
 ER/PR statusa
  ER+/PR+ 96.0 (92.7–99.3) 83.7 (80.7–86.8) 76.0 (74.7–77.3) 65.9 (64.7–67.2)
  ER+/PR- 19.5 (18.0–21.0) 15.3 (14.1–16.7) 15.9 (15.3–16.5) 14.1 (13.5–14.6)
  ER-/PR+ 2.3 (1.8–2.9) 1.0 (0.7–1.4) 1.9 (1.7–2.1) 1.3 (1.1–1.5)
  ER-/PR- 21.6 (20.1–23.3) 20.3 (18.8–21.9) 20.5 (19.8–21.3) 19.6 (18.9–20.2)
  Missing 20.7 (19.3–22.3) 20.3 (18.9–21.9) 37.4 (36.5–38.4) 34.3 (33.4–35.1)
 Stage at diagnosisa
  Localized 103.4 (100.1–106.8) 93.1 (89.9–96.4) 95.0 (93.5–96.5) 84.6 (83.3–86.0)
  Regional 48.4 (46.1–50.8) 40.5 (38.4–42.7) 47.8 (46.8–48.9) 42.0 (41.0–43.0)
  Distant 6.0 (5.2–6.9) 5.3 (4.5–6.1) 5.4 (5.0–5.8) 5.5 (5.2–5.9)
  Unstaged/Not available 2.3 (1.8–2.8) 1.5 (1.1–1.9) 3.4 (3.2–3.7) 2.2 (2.0–2.5)
 Tumor size
  <2 cm 93.4 (90.2–96.7) 82.6 (79.6–85.7) 84.8 (83.4–86.2) 73.9 (72.6–75.2)
  ≥2 cm 58.1 (55.6–60.7) 51.6 (49.2–54.1) 58.2 (57.0–59.4) 53.5 (52.4–54.6)
  Unknown 8.5 (7.6–9.5) 6.1 (5.3–6.9) 8.8 (8.3–9.2) 7.1 (6.7–7.5)

All rates per 100,000 and age-adjusted to the 2000 US age standard. aInvasive breast cancer. CI, confidence interval; ER, estrogen receptor. Data from the California Cancer Registry.